Company Files Quarterly Report on Financial and Operations Results from the Period Ending June 30, 2020
Summary:
– GrowLife experienced revenue growth of 11% quarter-over-quarter in the second quarter of 2020 as compared to the first quarter of 2020, from $1.7M to $1.8M
– GrowLife increased its blended gross margins to 39.3% for the period ending June 30, 2020, up from 30.7% in the same quarter of 2019
– GrowLife reported a $1M sales order backlog, not included in revenue, to be shipped in the third quarter of 2020 and setting a revenue floor for the quarter not previously seen in the company’s history
– GrowLife increased gross profit for the quarter to $0.7M, an increase over the same quarter last year
– GrowLife reduced operating expenses for the six-month period ending June 30, 2020 by $1.7M when compared to the same period in 2019.
– GrowLife experienced increased demand for its commercial line of EZ-CLONE plant propagators fueled by growing demand for CBD-rich hemp and essential classification of cannabis across the country
KIRKLAND, Wash. — GrowLife, Inc. (OTC: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, today announced financial results for the period ending June 30, 2019 and provided an insight into the company’s position in the Management’s Discussion and Analysis section of the filing.
The Company reported growth in its revenue over the last quarter, reporting $1.8M for the period ending June 30, 2020, an increase of 11% quarter-over-quarter. In addition to the revenue generated, the company also reported a $1M backlog of sales, scheduled to ship in the third quarter 2020, effectively starting the third quarter with a base of $1M in revenue. Further, as a result of the cost reduction measures implemented in 2019, the company reported increased gross margins of 39.3%, up from 30.7% when compared to the same quarter in 2019 and a gross profit of $0.7M for the second quarter 2020. Finally, GrowLife reduced its operating expenses by $1.7M during the six months ending June 30, 2020 and reduced cashed used in operations by $1.2M, from $2.1M to $0.9M.
“While others are pulling back due to the pandemic and other conditions, we are so happy to announce an up quarter where our revenue beat last quarter, we saw further increases in gross margins, and have an outstanding backlog of sales revenue,” said GrowLife CEO Marco Hegyi. “We continued to operate throughout the pandemic as an essential service, providing the equipment necessary for hemp farmers and cannabis operators to continue to plant during the pivotal spring season. Beginning in March, we saw a significant increase in demand for our EZ-CLONE commercial cloning units, one of our highest priced items with attritive margins. This demand resulted in us reporting a one-million-dollar backlog in sales, something extremely noteworthy. This is a key metric I want to highlight,. Even without it, we were able to report quarter-over-quarter growth and year-over-year increased margins. This is really exciting and the fact that we are growing during these unprecedented times, speaks volumes to how we are positioned as a company.”
Q2 2020 FINANCIAL RESULTS
Net Revenue: For the period ending June 30, 2020, GrowLife showed net revenue of $1,849,837, as compared to revenue of $1,661,800 for the period ending March 31, 2020 – an increase of 11.3%.
Gross Profit: For the period ending June 30, 2020, GrowLife had a Gross Profit of $727,831 as compared to $675,773 the period ending March 31, 2020 – an increase of approximately 7.7%.
Net Loss: For the period ending June 30, 2020, GrowLife had a Net Loss of $610,523 as compared to a loss of $1,376,996 for the period ending June 30, 2019.
Cash Flow used in Operations: For the six-month period ending June 30, 2020, GrowLife had Cash Flow Used in Operations of $905,804 as compared to $2,097,363 for the same six-month period ending June 30, 2019.
Disclaimer
All stock recommendations and comments are the opinions of the writer.
Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion.
All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.
You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. Neither Market-Advisor.com nor any of its suppliers guarantee its accuracy or validity, nor are they responsible for any errors or omissions which may have occurred. The analysis, ratings, and/or recommendations made by Market-Advisor.com, and/or any of its suppliers do not provide, imply, or otherwise constitute a guarantee of performance.
Market-Advisor.com is comprised of reports, if any, embodying a unique system of stock analysis. Accuracy and completeness cannot be guaranteed. Users should be aware of the risks involved in stock investments. It should not be assumed that future results will be profitable or will equal past performance, real, indicated, or implied.
The material on this website is provided for information purposes only. Market-Advisor.com does not accept liability for your use of the website. The website is provided on an “as is” and “as available” basis, without any representations, warranties, or conditions of any kind.
